3
Views
1
CrossRef citations to date
0
Altmetric
CNS Agents

Overview: Cell Transplant Therapy for Neurodegenerative Disease

, &
Pages 1671-1680 | Published online: 02 Mar 2011

References to Primary Literature

  • The Surgeon General's Report on Health and Nutrition US Dept Health and Human Services Washington, DC. 1988.
  • Kurland, LT Kurtze, JF Goldberg, ID Epidemiology of neurologic and sense organ disorders. Harvard University Press Cambridge, MA. 1973.
  • Brodal, A Neurological anatomy. Oxford University Press Oxford 1981.
  • Cotzias, GC Papavasiliou, PS Gellene, R Modification of Parkinsonism-chronic treatment with l-dopa. New Engl. J. Med. 1969 280 337–345 Seminal paper in the field of l-dopa therapy.
  • Yahr, MD Elizan, TS Moros, D Selegine in the treatment of Parkinson's disease - long term experience. Acta Neurol. Scand. 1989 126 157–161.
  • Macdonald, RL McLean, MJ Anticonvulsant drugs: Mechanisms of action. Adv. Neurol. 1986 44 713–736 Discusses clinical experience with anticonvulsants.
  • Adams, RD Maurice, V Principles of neurology, 3rd ed. McGraw Hill New York 1985.
  • Guldvog, B Løyning, Y Hauglie-Hanssen, E Flood, S Bjørnæs, H Surgical versus medical treatment for epilepsy. I. Outcome related to survival, seizures and neurologic deficit. Epilepsia 1991 32 375–388 Success of surgical intervention for epilepsy.
  • Ramussen, T Surgery for central, parietal and occipital epilepsy. Can. J. Neurol. Sci. 1991 18 4 611–616.
  • Trimble, MR Biological Psychiatry John Wiley & Sons Chichester 1988.
  • Itakura, T Yokote, H Yukawa, S Narai, M Umemoto, M Transplantation of peripheral cholinergic neurons into Alzheimer model rat brain. Stereotactic and Functional Neurosurgery 1990 54–55 368–372 Animal model for Alzheimer's disease.
  • Pawlik, G Holthoff, VA Kessler, J Rudolf, J Hebold, IR Lottgen, J Heiss, WD Positron emission tomography findings relevant to neurosurgery for epilepsy. Acta Neurochirurg. 1990 50 84–87 (Suppl)
  • Jellinger, K New developments in the pathology of Parkinson's disease. Adv. Neurol. 1990 53 1–16.
  • Talairach, J Bancaud, J Bonis, A Szikla, G Trottier, S Vignal, JP Chauvel, P Munari, C Chodkievicz, JP Surgical therapy for frontal epilepsies. Adv. Neurol. 1992 57 707–732.
  • Stereotactic Neurosurgery. Neurosurgery Clinics of North America Friedman, WA 1990 Volume 1 Excellent overview and in-depth coverage of topics related to neurosurgical approach to brain disease.
  • Olson, L Seiger, A Brain tissue transplanted to the anterior chamber of the eye. Z. Zellforsch. Mikrosk. Anat. 1972 135 175–194.
  • Olson, L Seiger, A Hoffer, B Taylor, D Isolated catecholaminergic projections from substantia nigra and locus coeruleus to caudate hippocampus and cerebral cortex formed by intraocular sequential double brain grafts. Exp. Brain Res. 1979 35 47–67.
  • Perlow, M Freed, W Hoffer, B Seiger, A Olson, L Wyatt, R Brain grafts reduce motor abnormalities produced by the destruction of nigrostriatal dopamine system. Science 1979 204 643–647.
  • Ungerstedtt, U Arbuthnott, GW Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 1970 24 483–485 Description of rat model for Parkinson's disease.
  • Bjorklund, A Stenevi, U Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 1979 177 555–560.
  • Burns, RS Chiueh, CC Markey, SP Ebert, MH Jacobwrrz, DM Kopin, IJ A primate model for parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 1984 111 108–113 Primate model for Parkinson's disease.
  • Goldstein, M Lieberman, AN Takasugi, N Shimizu, Y Kuga, S The antiparkinsonian activity of dopamine agonists and their interaction with central dopamine receptor subtypes. Adv. Neurol. 1990 53 101–106.
  • Bjorklund, A Stenevi, U Schmidt, RH Dunnett, SB Gage, FH Intracerebral grafting of neuronal cell suspensions. Acta Physiol. Scand. Suppl. 1983 522 9–18.
  • Freed, W Morihisa, J Spoor, E Hoffer, B Olson, L Seiger, A Wyatt, R Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Nature 1981 292 351–352.
  • Unsicker, K Kirsch, B Otten, U Thoen, H Nerve growth factor induces fiber outgrowth from isolated rat adrenal chromaffin cells. Proc. Natl. Acad. Sci. USA 1978 75 3498–3502.
  • Stromberg, I Herrara, M Ungerstedt, U Ebendal, T Olson, L Chronic implants of chromaffin tissue into the dopamine denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp. Brain. Res. 1985 60 335–349.
  • Goetz, GC Olanow, CW Koller, WC Multicenter study of autologous adrenal medullary transplantation to the corpus striatum of patients with advanced Parkinson's disease. New Engl. J. Med. 1989 320 337–331 Review of clinical experience of transplants for Parkinson's disease.
  • Chen, LS Ray, J Fisher, LJ Kawaja, MD Schinstine, M Kang, UJ Gage, FH Cellular replacement therapy for neurologic disorders: Potential of genetically engineered cells. J. Cellular Biochem. 1991 45 252–257 Reviews the use of genetically engineered cells for transplant.
  • Backlund, EO Granberg, PO Hamberger, B Transplantation of adrenal medullary tissue to striatum in Parkinsonism. J. Neurosurg. 1985 62 169–173.
  • Lindvall, O Backlund, EO Farde, L Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen. Ann. Neurol. 1987 22 457–468.
  • Madrazo, I Drucker-Colin, R Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. New Engl. J. Med. 1987 316 831–834.
  • Gildenberg, PL Pettigrew, LC Merell, R Butler, I Conklin, R Katz, J DeFrance, J Transplantation of adrenal medullary tissue to caudate nucleus using stereotactic techniques. Stereotact. Funct. Neurosurg. 1990 54 268–271.
  • Filndaca, MS Kordower, JH Hansen, JT Jiao, S Gash, DM Adrenal medullary autografts into the basal ganglia of the Cebus monkeys: Injury-induced regeneration. Exper. Neurol. 1988 102 76–91.
  • Freed, CR Breeze, RE Schneck, SA Kruse, C Rosenberg, NL Striatal implants of fetal dopamine cells improve signs on parkinson's disease Third IBRO World Congress of Neuroscience Abstracts 1991 109 One of the very few groups in the world still engaged in the use of foetal material.
  • Jankovic, J Grossman, R Goodman, C Pirozzolo, F Schneider, L Zhu, Z Scardino, P Garber, A Jhigran, SG Martin, S Clinical, biochemical and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease. Neurology 1989 39 1227–1234 Presents evidence that failed transplants are due to non-immunological causes.
  • Tresco, PA Winn, SR Zielinski, B Jaeger, CB Greene, LA Aebischer, P Effect of long-term polymer encapsulation of PC12 cells in vitro. Society for Neurosciences Abstracts 1990 16 39.

References to Patent Literature

  • Brown University Research Foundation US4892538 Patent claiming method of encapsulating cells to prevent neurological disorders.
  • The Regents of the University of California US5082670 Patent claiming the use of genetically engineered cells in the brain.
  • Dana Farber Cancer Institute WO9207945.
  • The Regents of the University of California WO9205272.
  • New York University WO9206702.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.